Haidar Maatouk

719 total citations
8 papers, 581 citations indexed

About

Haidar Maatouk is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haidar Maatouk has authored 8 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 2 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haidar Maatouk's work include Pharmacological Effects and Toxicity Studies (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Diabetes Treatment and Management (2 papers). Haidar Maatouk is often cited by papers focused on Pharmacological Effects and Toxicity Studies (3 papers), Blood Coagulation and Thrombosis Mechanisms (2 papers) and Diabetes Treatment and Management (2 papers). Haidar Maatouk collaborates with scholars based in Germany, United States and Switzerland. Haidar Maatouk's co-authors include Atef Halabi, Volkmar Lufft, Norbert Klause, Dagmar Kubitza, Wolfgang Mueck, Heike Bruck, Thomas Philipp, Michael Becka, Patrick Brossard and Jasper Dingemanse and has published in prestigious journals such as Blood, Clinical Pharmacokinetics and British Journal of Clinical Pharmacology.

In The Last Decade

Haidar Maatouk

8 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haidar Maatouk Germany 7 324 245 147 61 48 8 581
Christiane Tillmann Germany 11 158 0.5× 114 0.5× 40 0.3× 11 0.2× 47 1.0× 11 362
David Iyú Spain 12 193 0.6× 42 0.2× 69 0.5× 13 0.2× 22 0.5× 20 408
Daniel M. Purdham Canada 11 332 1.0× 74 0.3× 137 0.9× 22 0.4× 7 0.1× 15 714
Latonya Been United States 19 508 1.6× 122 0.5× 131 0.9× 13 0.2× 13 0.3× 36 835
J Szczeklik Poland 9 150 0.5× 43 0.2× 50 0.3× 29 0.5× 22 0.5× 31 485
Marian Tomasiak Poland 13 103 0.3× 27 0.1× 64 0.4× 24 0.4× 16 0.3× 25 376
Tobias Riexinger Germany 5 290 0.9× 45 0.2× 53 0.4× 51 0.8× 4 0.1× 8 569
S R Cockbill United Kingdom 10 199 0.6× 51 0.2× 31 0.2× 12 0.2× 13 0.3× 15 452
Gabriele Merciaro Italy 6 340 1.0× 85 0.3× 22 0.1× 10 0.2× 12 0.3× 6 561
Wolfgang Latz Germany 5 313 1.0× 61 0.2× 41 0.3× 5 0.1× 11 0.2× 5 508

Countries citing papers authored by Haidar Maatouk

Since Specialization
Citations

This map shows the geographic impact of Haidar Maatouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haidar Maatouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haidar Maatouk more than expected).

Fields of papers citing papers by Haidar Maatouk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haidar Maatouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haidar Maatouk. The network helps show where Haidar Maatouk may publish in the future.

Co-authorship network of co-authors of Haidar Maatouk

This figure shows the co-authorship network connecting the top 25 collaborators of Haidar Maatouk. A scholar is included among the top collaborators of Haidar Maatouk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haidar Maatouk. Haidar Maatouk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Amri, Mohamed, et al.. (2018). 506 The Importance of Communication Between Doctor and Patient in the Management of Erectile Dysfunction – a Clinical Study of 120 Cases. The Journal of Sexual Medicine. 15(Supplement_3). S309–S309. 1 indexed citations
2.
Brossard, Patrick, Michael W. Scherz, Atef Halabi, et al.. (2014). Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P1receptor modulator: Favorable impact of dose up-titration. The Journal of Clinical Pharmacology. 54(2). 179–188. 58 indexed citations
3.
Halabi, Atef, et al.. (2013). Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment. Clinical Pharmacology in Drug Development. 3(4). 290–296. 11 indexed citations
4.
Cawello, Willi, Uwe Fuhr, Ursula Hering, Haidar Maatouk, & Atef Halabi. (2013). Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide. Clinical Pharmacokinetics. 52(10). 897–906. 31 indexed citations
5.
Halabi, Atef, et al.. (2013). Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment. Clinical Pharmacology in Drug Development. 2(3). 246–254. 32 indexed citations
6.
Brossard, Patrick, Hartmut Derendorf, Jian Xu, et al.. (2013). Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first‐in‐human study. British Journal of Clinical Pharmacology. 76(6). 888–896. 95 indexed citations
7.
Kubitza, Dagmar, Michael Becka, Wolfgang Mueck, et al.. (2010). Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. British Journal of Clinical Pharmacology. 70(5). 703–712. 334 indexed citations
8.
Halabi, Atef, Haidar Maatouk, Norbert Klause, et al.. (2006). Effects of Renal Impairment on the Pharmacology of Rivaroxaban (BAY 59-7939) - An Oral, Direct, Factor Xa Inhibitor.. Blood. 108(11). 913–913. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christiane Tillmann Breakdown of academic impact, for papers by David Iyú Breakdown of academic impact, for papers by Daniel M. Purdham Breakdown of academic impact, for papers by Latonya Been Breakdown of academic impact, for papers by J Szczeklik Breakdown of academic impact, for papers by Marian Tomasiak Breakdown of academic impact, for papers by Tobias Riexinger Breakdown of academic impact, for papers by S R Cockbill Breakdown of academic impact, for papers by Gabriele Merciaro Breakdown of academic impact, for papers by Wolfgang Latz
Rankless by CCL
2026